{{PBB|geneid=567}}
'''β<sub>2</sub> microglobulin''' also known as '''B2M''' is a component of [[MHC class I]] molecules, which are present on all nucleated cells (excludes [[red blood cell]]s).<ref name="entrez_567">{{cite web | title = Entrez Gene: Beta-2-microglobulin| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=567| accessdate = }}</ref><ref name="pmid3312414">{{cite journal | author = Güssow D, Rein R, Ginjaar I, Hochstenbach F, Seemann G, Kottman A, Ploegh HL | title = The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit | journal = J. Immunol. | volume = 139 | issue = 9 | pages = 3132–8 | date=1 November 1987| pmid = 3312414 | url = http://www.jimmunol.org/cgi/content/abstract/139/9/3132 }}</ref>  In humans, the β<sub>2</sub> microglobulin [[protein]]<ref name="pmid4586824">{{cite journal | author = Cunningham BA, Wang JL, Berggård I, Peterson PA | title = The complete amino acid sequence of beta 2-microglobulin | journal = Biochemistry | volume = 12 | issue = 24 | pages = 4811–22 | year = 1973 | month = November | pmid = 4586824 | doi = 10.1021/bi00748a001| url =  }}</ref> is encoded by the ''B2M'' [[gene]].<ref name="pmid3312414"/><ref name="pmid6171820">{{cite journal | author = Suggs SV, Wallace RB, Hirose T, Kawashima EH, Itakura K | title = Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 78 | issue = 11 | pages = 6613–7 | year = 1981 | month = November | pmid = 6171820 | pmc = 349099 | doi = 10.1073/pnas.78.11.6613| url =  }}</ref>

==Structure and function==
[[Image:MHC Class 1.svg|thumb|left|Schematic representation of MHC class I]]
β<sub>2</sub> microglobulin lies lateral to the α<sub>3</sub> chain on the cell surface. Unlike α<sub>3</sub>, β<sub>2</sub> has no [[Transmembrane protein|transmembrane]] region. Directly above β<sub>2</sub> (i.e. away from the cell) lies the α<sub>1</sub> chain, which itself is lateral to the α<sub>2</sub>.

β<sub>2</sub> microglobulin associates not only with the alpha chain of MHC class I molecules, but also with class I-like molecules such as [[CD1]] and [[Alloantigen|Qa]].

An additional function is association with the [[HFE protein]], together regulating the expression of [[hepcidin]] in the [[liver]] which targets the iron transporter [[ferroportin]] on the cytoplasmic membrane of [[enterocytes]] and [[macrophages]] for degradation resulting in decreased iron uptake from food and iron release from recycled red blood cells respectively. Loss of this function causes iron excess and [[hemochromatosis]].

==Clinical significance==
In patients on long-term [[hemodialysis]], it can aggregate into [[amyloid]] fibers that deposit in joint spaces, a disease known as [[dialysis-related amyloidosis]].

Mice models deficient for the β<sub>2</sub> microglobulin gene have been engineered. These mice demonstrate that β<sub>2</sub> microglobulin is necessary for cell surface expression of MHC class I and stability of the peptide binding groove. In fact, in the absence of β<sub>2</sub> microglobulin, very limited amounts of MHC class I (classical and non-classical) molecules can be detected on the surface. In the absence of MHC class I, [[CD8]] T cells cannot develop. (CD8 T cells are a subset of T cells involved in the development of acquired immunity.) Low levels of β<sub>2</sub> microglobulin can indicate non-progression of HIV.

Levels of beta-2 microglobulin can be elevated in [[multiple myeloma]] and [[lymphoma]], though in these cases primary amyloidosis (amyloid light chain) and secondary amyloidosis (Amyloid associated protein) are more common. The normal value of beta-2 microglobulin is <0.2&nbsp;mg/dL.<ref name="isbn0-07-141184-4">{{cite book | author = Pignone M, Nicoll D; McPhee SJ | title = Pocket guide to diagnostic tests | edition = 4th | publisher = McGraw-Hill | location = New York | year = 2004 | pages =191 | isbn = 0-07-141184-4 }}</ref> However, with respect to multiple myeloma, the levels of beta2-microglobulin may also be at the other end of the spectrum.  Diagnostic testing for multiple myeloma includes obtaining the beta2-microglobulin level, for this level is an important prognostic indicator.  A patient with a level <0.004 g/L is expected to have a median survival of 43 months, while one with a level >0.004 g/L has a median survival of only 12 months.<ref name="isbn0-07-174889-X">{{cite book | editor = Loscalzo J, Longo DL, Fauci AS, Dennis LK, Hauser SL | title = Harrison's Principles of Internal Medicine | author = Munshi NC, Longo DL, Anderson KC | chapter = Chapter 111: Plasma Cell Disorders  | pages = 936–44| edition = 18th | publisher = McGraw-Hill Professional | location = | year = 2011 | isbn = 0-07-174889-X }}</ref>

==References==
{{Reflist}}

==Further reading==
{{Refbegin | 2}}
{{PBB_Further_reading 
| citations = 
*{{cite journal  | author=Huang WC, Havel JJ, Zhau HE, Qian WP, Lue HW, Chu CY, Nomura T, Chung LW.|title=β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells |journal=Clin. Cancer Res.  |volume=14 |issue= 17 |pages= 5341–7 |year= 2008 |pmid= 18765525  | doi=10.1158/1078-0432.CCR-08-0793  | pmc=3032570}}
*{{cite journal  | author=Huang WC, Wu D, Xie Z, Zhau HE, Nomura T, Zayzafoon M, Pohl J, Hsieh CL, Weitzmann MN, Farach-Carson MC, Chung LW.|title=Beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis |journal=Cancer Res.  |volume=66 |issue= 18 |pages= 9108–16 |year= 2006 |pmid= 16982753  | doi=10.1158/0008-5472.CAN-06-1996}}
*{{cite journal  | author=Winchester JF, Salsberg JA, Levin NW |title=Beta-2 microglobulin in ESRD: an in-depth review |journal=Advances in renal replacement therapy |volume=10 |issue= 4 |pages= 279–309 |year= 2004 |pmid= 14681859 |doi=10.1053/j.arrt.2003.11.003  }}
*{{cite journal  | author=Krangel MS, Orr HT, Strominger JL |title=Assembly and maturation of HLA-A and HLA-B antigens in vivo |journal=Cell |volume=18 |issue= 4 |pages= 979–91 |year= 1980 |pmid= 93026 |doi=10.1016/0092-8674(79)90210-1  }}
*{{cite journal  | author=Okon M, Bray P, Vucelić D |title=1H NMR assignments and secondary structure of human beta 2-microglobulin in solution |journal=Biochemistry |volume=31 |issue= 37 |pages= 8906–15 |year= 1992 |pmid= 1390678 |doi=10.1021/bi00152a030  }}
*{{cite journal  | author=Guo HC |title=Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle |journal=Nature |volume=360 |issue= 6402 |pages= 364–6 |year= 1992 |pmid= 1448153 |doi= 10.1038/360364a0  | author-separator=,  | author2=Jardetzky TS  | author3=Garrett TP  | display-authors=3  | last4=Lane  | first4=William S.  | last5=Strominger  | first5=Jack L.  | last6=Wiley  | first6=Don C. }}
*{{cite journal  | author=Gattoni-Celli S, Kirsch K, Timpane R, Isselbacher KJ |title=Beta 2-microglobulin gene is mutated in a human colon cancer cell line (HCT) deficient in the expression of HLA class I antigens on the cell surface |journal=Cancer Res. |volume=52 |issue= 5 |pages= 1201–4 |year= 1992 |pmid= 1737380 |doi=  }}
*{{cite journal  | author=Saper MA, Bjorkman PJ, Wiley DC |title=Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution |journal=J. Mol. Biol. |volume=219 |issue= 2 |pages= 277–319 |year= 1991 |pmid= 2038058 |doi=10.1016/0022-2836(91)90567-P  }}
*{{cite journal  | author=Caruana RJ |title=Tumor necrosis factor, interleukin-1 and beta 2-microglobulin levels in chronic hemodialysis patients |journal=The International journal of artificial organs |volume=13 |issue= 12 |pages= 794–8 |year= 1991 |pmid= 2289831 |doi=  | author-separator=,  | author2=Lobel SA  | author3=Leffell MS  | display-authors=3  | last4=Campbell  | first4=H  | last5=Cheek  | first5=PL  }}
*{{cite journal  | author=Connors LH |title=In vitro formation of amyloid fibrils from intact beta 2-microglobulin |journal=Biochem. Biophys. Res. Commun. |volume=131 |issue= 3 |pages= 1063–8 |year= 1985 |pmid= 2413854 |doi=10.1016/0006-291X(85)90198-6  | author-separator=,  | author2=Shirahama T  | author3=Skinner M  | display-authors=3  | last4=Fenves  | first4=A.  | last5=Cohen  | first5=A.S.  }}
*{{cite journal  | author=Hochman JH, Shimizu Y, DeMars R, Edidin M |title=Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin |journal=J. Immunol. |volume=140 |issue= 7 |pages= 2322–9 |year= 1988 |pmid= 2450918 |doi=  }}
*{{cite journal  | author=Homma N, Gejyo F, Isemura M, Arakawa M |title=Collagen-binding affinity of beta-2-microglobulin, a preprotein of hemodialysis-associated amyloidosis |journal=Nephron |volume=53 |issue= 1 |pages= 37–40 |year= 1989 |pmid= 2674742 |doi=10.1159/000185699  }}
*{{cite journal  | author=Bataille R, Grenier J, Commes T |title=In vitro production of beta 2 microglobulin by human myeloma cells |journal=Cancer Invest. |volume=6 |issue= 3 |pages= 271–7 |year= 1988 |pmid= 3048575 |doi=10.3109/07357908809080649  }}
*{{cite journal  | author=Hönig R |title=Correlation of beta-2-microglobulin concentration changes to changes of distribution volume |journal=The International journal of artificial organs |volume=11 |issue= 6 |pages= 459–64 |year= 1989 |pmid= 3060434 |doi=  | author-separator=,  | author2=Marsen T  | author3=Schad S  | display-authors=3  | last4=Barth  | first4=C  | last5=Pollok  | first5=M  | last6=Baldamus  | first6=CA  }}
*{{cite journal  | author=Bjorkman PJ |title=Structure of the human class I histocompatibility antigen, HLA-A2 |journal=Nature |volume=329 |issue= 6139 |pages= 506–12 |year= 1987 |pmid= 3309677 |doi= 10.1038/329506a0  | author-separator=,  | author2=Saper MA  | author3=Samraoui B  | display-authors=3  | last4=Bennett  | first4=W. S.  | last5=Strominger  | first5=J. L.  | last6=Wiley  | first6=D. C. }}
*{{cite journal  | author=Güssow D |title=The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit |journal=J. Immunol. |volume=139 |issue= 9 |pages= 3132–8 |year= 1987 |pmid= 3312414 |doi=  | author-separator=,  | author2=Rein R  | author3=Ginjaar I  | display-authors=3  | last4=Hochstenbach  | first4=F  | last5=Seemann  | first5=G  | last6=Kottman  | first6=A  | last7=Ploegh  | first7=HL  }}
*{{cite journal  | author=Cunningham BA, Wang JL, Berggård I, Peterson PA |title=The complete amino acid sequence of beta 2-microglobulin |journal=Biochemistry |volume=12 |issue= 24 |pages= 4811–22 |year= 1974 |pmid= 4586824 |doi=10.1021/bi00748a001  }}
*{{cite journal  | author=Suggs SV |title=Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=78 |issue= 11 |pages= 6613–7 |year= 1982 |pmid= 6171820 |doi=10.1073/pnas.78.11.6613  | pmc=349099  | author-separator=,  | author2=Wallace RB  | author3=Hirose T  | display-authors=3  | last4=Kawashima  | first4=EH  | last5=Itakura  | first5=K  }}
*{{cite journal  | author=Momoi T |title=Amino acid sequence of a modified beta 2-microglobulin in renal failure patient urine and long-term dialysis patient blood |journal=Clin. Chim. Acta |volume=236 |issue= 2 |pages= 135–44 |year= 1995 |pmid= 7554280 |doi=10.1016/0009-8981(95)06039-G  | author-separator=,  | author2=Suzuki M  | author3=Titani K  | display-authors=3  | last4=Hisanaga  | first4=Shuichi  | last5=Ogawa  | first5=Hiroshi  | last6=Saito  | first6=Akira  }}
*{{cite journal  | author=Collins EJ, Garboczi DN, Karpusas MN, Wiley DC |title=The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=92 |issue= 4 |pages= 1218–21 |year= 1995 |pmid= 7862664 |doi=10.1073/pnas.92.4.1218  | pmc=42670  }}
*{{cite journal  | author=Matoba R |title=The addition of 5'-coding information to a 3'-directed cDNA library improves analysis of gene expression |journal=Gene |volume=146 |issue= 2 |pages= 199–207 |year= 1994 |pmid= 8076819 |doi=10.1016/0378-1119(94)90293-3  | author-separator=,  | author2=Okubo K  | author3=Hori N  | display-authors=3  | last4=Atsushi  | first4=Fukushima  | last5=Kenichi  | first5=Matsubara  }}
*{{cite journal  | author=Wang Z |title=Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA |journal=J. Clin. Invest. |volume=91 |issue= 2 |pages= 684–92 |year= 1993 |pmid= 8432869 |doi=10.1172/JCI116249  | pmc=288010  | author-separator=,  | author2=Cao Y  | author3=Albino AP  | display-authors=3  | last4=Zeff  | first4=R A  | last5=Houghton  | first5=A  | last6=Ferrone  | first6=S  }}
}}
{{Refend}}

==External links==
* {{MeshName|beta+2-Microglobulin}}

<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes 
| require_manual_inspection = no 
| update_protein_box = yes
| update_summary = no
| update_citations = yes
}}

{{PDB Gallery|geneid=567}}
{{Beta globulins}}
{{Amyloidosis}}

{{DEFAULTSORT:Beta-2 Microglobulin}}
[[Category:Proteins]]
[[Category:Immune system]]